Injected Xolair Therapy Could Prevent Food Allergies in Kids
THURSDAY, Dec. 21, 2023 -- A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results.
A lab-made monoclonal antibody called omalizumab (Xolair) significantly increased the amounts of common...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Allergy | Allergy & Immunology | Children | Clinical Trials | Food Allergy | General Medicine | Xolair